Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cuicui完成签到,获得积分10
刚刚
刚刚
思源应助超级寒珊采纳,获得10
刚刚
英吉利25发布了新的文献求助20
刚刚
36456657应助温柔采纳,获得10
刚刚
刚刚
菠菜发布了新的文献求助30
1秒前
1秒前
XiiiU关注了科研通微信公众号
1秒前
ding应助多喝水采纳,获得20
2秒前
2秒前
hwyk完成签到,获得积分10
2秒前
Orange应助想啊想采纳,获得10
2秒前
老迟到的凌兰完成签到,获得积分10
2秒前
2秒前
闪闪发布了新的文献求助10
2秒前
3秒前
IleraYoung发布了新的文献求助10
3秒前
无情伟祺发布了新的文献求助20
4秒前
4秒前
我不吃柠檬完成签到,获得积分10
4秒前
量子星尘发布了新的文献求助10
4秒前
hah发布了新的文献求助10
5秒前
cmy完成签到,获得积分20
5秒前
5秒前
5秒前
6秒前
6秒前
秦英杰发布了新的文献求助10
6秒前
领导范儿应助娇气的芷巧采纳,获得10
6秒前
王灰灰1完成签到 ,获得积分10
6秒前
科研小白发布了新的文献求助10
6秒前
中和皇极应助合适的雁易采纳,获得10
7秒前
7秒前
美满烤鸡发布了新的文献求助10
7秒前
Akim应助purple采纳,获得10
7秒前
8秒前
111完成签到,获得积分10
8秒前
8秒前
sun发布了新的文献求助10
8秒前
高分求助中
Theoretical Modelling of Unbonded Flexible Pipe Cross-Sections 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
《药学类医疗服务价格项目立项指南(征求意见稿)》 880
花の香りの秘密―遺伝子情報から機能性まで 800
3rd Edition Group Dynamics in Exercise and Sport Psychology New Perspectives Edited By Mark R. Beauchamp, Mark Eys Copyright 2025 600
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Digital and Social Media Marketing 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5619405
求助须知:如何正确求助?哪些是违规求助? 4704160
关于积分的说明 14926129
捐赠科研通 4759826
什么是DOI,文献DOI怎么找? 2550547
邀请新用户注册赠送积分活动 1513336
关于科研通互助平台的介绍 1474401